NCT02858310 2026-03-09
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
Clinical Trials
143 trialsNCT02749110 2026-02-05
PaCUDAHL-Gé
University Hospital, Lille
Phase NA Completed
NCT01639820 2025-12-19
SENTICOL2
Hospices Civils de Lyon
Phase NA Completed
NCT05509413 2025-11-18
HPV-VG1
Ruhr University of Bochum
Phase NA Completed
NCT06165614 2025-08-19
Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT03429582 2025-07-17
Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device
The Cleveland Clinic
Phase NA Completed
NCT06054841 2025-06-29
Reshaping Postpartum Follow-up
Medstar Health Research Institute
Phase NA Completed
NCT06562595 2025-05-20
What is the Optimal Training Model for Cervical Awareness?
Izmir City Hospital
Phase NA Completed
NCT03196180 2025-04-08
Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Completed
NCT03084081 2025-04-06
UH3
The Cleveland Clinic
Phase NA Completed
NCT06149598 2025-03-04
Coughing at Time of Cervical Biopsy
Zydolab - Institute of Cytology and Immune Cytochemistry
Phase NA Completed
NCT05496231 2025-02-03
A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age
GlaxoSmithKline
Phase 1/2 Completed
NCT03493542 2024-12-31
V501-213
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03721978 2024-10-17
REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
Inovio Pharmaceuticals
Phase 3 Completed
NCT03218436 2024-07-23
CAPCIN
University Hospital Tuebingen
Phase NA Completed
NCT02956239 2024-07-08
DELTA
International Agency for Research on Cancer
Phase NA Completed
NCT04753073 2024-07-05
ZGynO_CINIII
University Hospital Tuebingen
Phase NA Completed
NCT02864147 2024-05-02
Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)
Yale University
Phase 2 Completed
NCT00667563 2024-03-19
Vaccine Therapy in Preventing HPV in HIV-Positive Women in India
AIDS Malignancy Consortium
Phase 1 Completed
NCT03629886 2024-03-15
Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study
GlaxoSmithKline
Phase 4 Completed
NCT01865929 2024-03-04
Minimally Invasive Benign Hysterectomy
Region Skane
Phase NA Completed
NCT05234112 2024-02-22
PRESCRIP-TEC
University Medical Center Groningen
Phase NA Completed
NCT02481414 2023-12-18
A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions
University of Arkansas
Phase 2 Completed
NCT04679675 2023-09-18
STEP
Kaiser Permanente
Phase NA Completed
NCT00788164 2023-08-31
Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT05996796 2023-08-18
Dry Run of the ScreenUrSelf Trial
Universiteit Antwerpen
Phase NA Completed
NCT03185013 2023-07-27
REVEAL 1
Inovio Pharmaceuticals
Phase 3 Completed
NCT05756192 2023-07-11
Educational Video's Impact on Knowledge Regarding Cervical Cancer Screening
George Washington University
Phase NA Completed
NCT02740777 2023-04-13
Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females
Shanghai Zerun Biotechnology Co.,Ltd
Phase 2 Completed
NCT00873288 2023-03-21
Activating Collaborative CIS Support Via Targeted Provider Mailing
Northwestern University
Phase NA Completed
NCT02733068 2022-12-19
A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.
Shanghai Zerun Biotechnology Co.,Ltd
Phase 3 Completed
NCT05485259 2022-08-03
Effect of Alpha-lipoic Acid on Regression of Low-grade Squamous Intraepithelial Lesions (LSIL)
University of Zagreb
Phase NA Completed
NCT02206048 2022-07-25
Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix
M.D. Anderson Cancer Center
Phase NA Completed
NCT02330471 2022-07-08
CONE-1
Ruhr University of Bochum
Phase 3 Completed
NCT02476500 2022-07-08
LLETZ-1
Ruhr University of Bochum
Phase NA Completed
NCT05426148 2022-06-29
Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female
Xiamen Innovax Biotech Co., Ltd
Phase 4 Completed
NCT04530201 2022-06-15
CASUS-WP4
Universiteit Antwerpen
Phase NA Completed
NCT04298957 2022-05-18
See and Treat in an Outpatient Setting in Women Above 45 Years With Cervical Dysplasia
University of Aarhus
Phase NA Completed
NCT04154644 2022-01-14
CryoPop
Jhpiego
Phase NA Completed
NCT04911075 2021-12-02
Depth of Necrosis in Normal Cervical Epithelium After 85% Trichloroacetic Acid (TCA) Application
Indonesia University
Phase NA Completed
NCT00000758 2021-11-04
A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 3 Completed
NCT00001073 2021-11-04
Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 3 Completed
NCT03436251 2021-08-18
HPV
First Hospital of China Medical University
Phase NA Completed
NCT02367625 2021-04-08
Performance, Safety, and Efficacy of a New Cyrotherapy Device for Cervical Dysplasia
Jhpiego
Phase NA Completed
NCT03502798 2021-02-18
Coherence Imaging of the Cervical Epithelium With Scanning a/LCI
Duke University
Phase NA Completed
NCT03697226 2021-01-13
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.
Antiva Biosciences
Phase 1 Completed
NCT03510273 2020-11-27
Honduras Liger Thermocoagulator Study
PATH
Phase NA Completed
NCT00804466 2020-11-25
Human Papillomavirus Epidemiology in Nigeria
National Institutes of Health Clinical Center (CC)
Phase NA Completed
NCT03355820 2020-11-19
A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study
GlaxoSmithKline
Phase 3 Completed
NCT02095561 2020-09-09
EMA
Instituto Nacional del Cáncer, Argentina
Phase NA Completed